INTERNATIONAL PATENT: OMNISEQ, INC., PABLA, SARABJOT, SEAGER, JR., ROBERT JOHN, VAN ROEY, ERIK, GAO, SHUANG, CONROY, JEFFREY M. FILES APPLICATION FOR "CANCER TESTIS ANTIGEN BURDEN (CTAB) AS A BIOMARKER OF TUMOR-ASSOCIATED ANTIGENS"

GENEVA, March 25 -- OMNISEQ, INC. (700 Ellicott StreetBuffalo, New York 14203), PABLA, Sarabjot (700 Ellicott StreetBuffalo, New York 14203), SEAGER, JR., Robert John (700 Ellicott StreetBuffalo, New York 14203), VAN ROEY, Erik (700 Ellicott StreetBuffalo, New York 14203), GAO, Shuang (700 Ellicott StreetBuffalo, New York 14203), CONROY, Jeffrey M. (700 Ellicott StreetBuffalo, New York 14203) filed a patent application (PCT/US2025/046237) for "CANCER TESTIS ANTIGEN BURDEN (CTAB) AS A BIOMARKER OF TUMOR-ASSOCIATED ANTIGENS" on Sep 12, 2025. With publication no. WO/2026/060295, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classificati...